PMID- 36028430
OWN - NLM
STAT- MEDLINE
DCOM- 20221018
LR  - 20221030
IS  - 1878-0539 (Electronic)
IS  - 1748-6815 (Linking)
VI  - 75
IP  - 10
DP  - 2022 Oct
TI  - A comparison of patient-reported outcome measures for dupuytren disease: A 
      prospective view.
PG  - 3774-3781
LID - S1748-6815(22)00347-3 [pii]
LID - 10.1016/j.bjps.2022.06.024 [doi]
AB  - Treatment success in Dupuytren s disease has traditionally been assessed by 
      clinical examination and physical measures, but based on patient orientation, 
      patient-reported outcome measures (PROMs) can be used to quantify treatment 
      impacts and health-related quality of life. The aim of this study was to compare 
      the most widely used PROMS in Dupuytren s disease, their psychometric properties, 
      and their association with objectively measured hand function. We show a 
      prospective study in which two disease-specific questionnaires (URAM scale and 
      SDSS) and two hand-specific questionnaires (briefMHQ and PEM) were administered 
      before and a month after the treatment with collagenase. Psychometric properties 
      (construct validity, internal consistency, test-retest reliability, internal and 
      external responsiveness, reliability, and minimal clinically important difference 
      (MCID)) were calculated for all the questionnaires. Ninety-two completed both 
      sets of questionnaires. Pre- and post-treatment scores were strongly correlated 
      (Spearman rho >0.6) for all questionnaires. High internal consistency (Cronbach 
      alpha >0.88) was observed for all the questionnaires. Test-retest reliability was 
      also significant, with an ICC of >0.50 in all cases. The MCID was similar for 
      three of the questionnaires (URAM, 11.528/45=0.256; SDSS, 5.079/20=0.254; and 
      PEM, 21.542/77=0.215) and somewhat lower for the briefMHQ (10.617/60=0.177). No 
      correlations were observed between treatment outcome and treated hand (r = 0.107; 
      p = 0.31), joint (r = 0.163; p = 0.12), or finger (r = -0.151; p = 0.15). In 
      conclusion, we did not find that any one questionnaire performed better than the 
      other in detecting perceived changes in health status among patients with 
      Dupuytren s disease treated with collagenase.
CI  - Copyright (c) 2022 Elsevier Ltd. All rights reserved.
FAU - Sanjuan-Cervero, Rafael
AU  - Sanjuan-Cervero R
AD  - Orthopedics and Trauma Department, Hospital de Denia, Denia, Partida Beniadla 
      s/n, 03700 Alicante, Spain. Electronic address: sanjuan.rafcer@gmail.com.
FAU - Gomez-Herrero, Diego
AU  - Gomez-Herrero D
AD  - Pharmacy Department. Hospital Vithas 9 de Octubre, Valencia, Spain; Doctor of 
      Pharmacy Program. University of Granada, Granada, Spain.
FAU - Poquet-Jornet, Jaime E
AU  - Poquet-Jornet JE
AD  - Pharmacy Department- Hospital de Denia, Denia, Alicante, Spain.
FAU - Pena-Molina, Fernando
AU  - Pena-Molina F
AD  - Orthopedics and Trauma Department, Hospital de Denia, Denia, Partida Beniadla 
      s/n, 03700 Alicante, Spain.
FAU - de la Iglesia, Nicolas H
AU  - de la Iglesia NH
AD  - Orthopedics and Trauma Department, Hospital de Denia, Denia, Partida Beniadla 
      s/n, 03700 Alicante, Spain.
FAU - Sanjuan-Arago, Aurora
AU  - Sanjuan-Arago A
AD  - Orthopedic and Trauma Nursery. Hospital de Denia, Denia, Alicante, Spain.
FAU - Vazquez-Ferreiro, Pedro
AU  - Vazquez-Ferreiro P
AD  - Ophthalmologic Department. Hospital Virxen da Xunqueira, Cee, A Coruna, Spain.
FAU - Carrera-Hueso, Francisco J
AU  - Carrera-Hueso FJ
AD  - Pharmacy Department. Hospital Universitario de La Plana, Villareal, Castellon, 
      Spain.
LA  - eng
PT  - Journal Article
DEP - 20220618
PL  - Netherlands
TA  - J Plast Reconstr Aesthet Surg
JT  - Journal of plastic, reconstructive & aesthetic surgery : JPRAS
JID - 101264239
SB  - IM
MH  - *Dupuytren Contracture/diagnosis/therapy
MH  - Humans
MH  - Patient Reported Outcome Measures
MH  - Prospective Studies
MH  - Psychometrics
MH  - Quality of Life
MH  - Reproducibility of Results
MH  - Surveys and Questionnaires
OTO - NOTNLM
OT  - BriefMHQ
OT  - Dupuytren s disease
OT  - PEM
OT  - PROMs
OT  - SDSS
OT  - URAM
COIS- Declaration of Competing Interest Authors declare that they do not have any 
      potential interest on the publication of this manuscript.
EDAT- 2022/08/27 06:00
MHDA- 2022/10/19 06:00
CRDT- 2022/08/26 22:06
PHST- 2021/08/10 00:00 [received]
PHST- 2022/03/07 00:00 [revised]
PHST- 2022/06/05 00:00 [accepted]
PHST- 2022/08/27 06:00 [pubmed]
PHST- 2022/10/19 06:00 [medline]
PHST- 2022/08/26 22:06 [entrez]
AID - S1748-6815(22)00347-3 [pii]
AID - 10.1016/j.bjps.2022.06.024 [doi]
PST - ppublish
SO  - J Plast Reconstr Aesthet Surg. 2022 Oct;75(10):3774-3781. doi: 
      10.1016/j.bjps.2022.06.024. Epub 2022 Jun 18.